𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Production of osteoprotegerin by prostate cancer cells suppresses trial induced apoptosis

✍ Scribed by Ingunn Holen; Colby Eaton; Freddie Hamdy; Peter Croucher

Book ID
118643581
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
204 KB
Volume
1
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Osteoprotegerin production by breast can
Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis
✍ Tilman D. Rachner; Peggy Benad; Martina Rauner; Claudia Goettsch; Shiv K. Singh; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

## Abstract Osteoprotegerin (OPG) is a decoy receptor for receptor activator of NF‐κB ligand (RANKL) and TNF‐related apoptosis‐inducing ligand (TRAIL). While RANKL is essential for osteoclastogenesis and facilitates breast cancer migration into bone, TRAIL promotes breast cancer apoptosis. We analy

Pristimerin induces apoptosis by targeti
Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells
✍ Huanjie Yang; Kristin R. Landis-Piwowar; Dayan Lu; Ping Yuan; Lihua Li; G. Prem- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Pristimerin is a natural product derived from the __Celastraceae__ and __Hippocrateaceae__ families that were used as folk medicines for antiinflammation in ancient times. Although it has been shown that pristimerin induces apoptosis in breast cancer cells, the involved mechanism of act